fluoxymesterone has been researched along with Cancer of Prostate in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (76.92) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, W; Chapman, MS; Finn, PD; Hong, MH; López, FJ; Marschke, KB; Miner, JN; Negro-Vilar, A; Rosen, J; Schrader, W; Turner, R; van Oeveren, A; Viveros, H; Zhi, L | 1 |
| Cheung, A; Driedger, AA | 1 |
| Ablin, RJ; Alrenga, D; Alsheik, H; Bush, IM; Guinan, PD; Sadoughi, W | 1 |
| Abe, K | 1 |
| Dawson, NA; Frank, JA; Gelmann, EP; Jacob, JL; Linehan, WM; McLeod, DG; Weiss, RB; Wilding, G | 1 |
| Bartholomew, M; Boucher, A; Caplan, R; Gordon, R; Harvey, H; Lipton, A; Manni, A; Santen, R; Simmonds, M; White-Hershey, D | 1 |
| Al-Mondhiry, H; Gordon, R; Manni, A; Owen, J | 1 |
| Boccardo, F; Decensi, A; Giberti, C; Giuliani, L; Guarneri, D; Martorana, G | 1 |
| Boucher, AE; Drago, J; Gordon, RA; Harvey, H; Lipton, A; Manni, A; Rohner, TJ; Santen, RJ; Simmonds, M; White-Hershey, D | 1 |
| Boucher, AE; Drago, J; Gordon, R; Harvey, H; Lipton, A; Manni, A; Rohner, T; Santen, RJ; Simmonds, M; Wettlaufer, J | 1 |
| Case, D; Cooper, MR; Muss, HB; Nelson, EC; Pope, E; Puckett, JB; Resnick, MI; Richards, F; Spurr, CL; Zekan, P | 1 |
| Odell, WD; Swerdloff, RS; Walsh, PC | 1 |
| Scott, WP | 1 |
1 review(s) available for fluoxymesterone and Cancer of Prostate
| Article | Year |
|---|---|
[Hormone therapy of neoplasms].
Topics: Adenoma, Islet Cell; Aminoglutethimide; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pancreatic Neoplasms; Prostatic Neoplasms; Tamoxifen | 1991 |
4 trial(s) available for fluoxymesterone and Cancer of Prostate
| Article | Year |
|---|---|
A pilot trial of chemohormonal therapy for metastatic prostate carcinoma.
Topics: Adenocarcinoma; Aged; Androgens; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Evaluation; Fluoxymesterone; Flutamide; Humans; Leuprolide; Male; Middle Aged; Neoplasms, Hormone-Dependent; Pilot Projects; Prostatic Neoplasms; Remission Induction; Survival Analysis | 1992 |
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome.
Topics: Acid Phosphatase; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Fluorouracil; Fluoxymesterone; Follow-Up Studies; Humans; Hydrocortisone; Male; Prostatic Neoplasms; Random Allocation; Testosterone; Time Factors | 1988 |
Androgen priming and response to chemotherapy in advanced prostatic cancer.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Fluoxymesterone; Humans; Hydrocortisone; Male; Middle Aged; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Random Allocation | 1986 |
Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Synergism; Fluorouracil; Fluoxymesterone; Humans; Hydrocortisone; Male; Methotrexate; Orchiectomy; Prostatic Neoplasms; Random Allocation; Spinal Cord Compression | 1987 |
8 other study(ies) available for fluoxymesterone and Cancer of Prostate
| Article | Year |
|---|---|
An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.
Topics: Administration, Oral; Aminoquinolines; Animals; Antineoplastic Agents, Hormonal; Biomechanical Phenomena; Cell Line, Tumor; Copulation; Fluoxymesterone; Humans; Lumbar Vertebrae; Male; Muscle, Skeletal; Orchiectomy; Osteosarcoma; Prostate; Prostatic Neoplasms; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Spodoptera | 2007 |
Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Middle Aged; Palliative Care; Parathyroid Hormone; Phosphorus Radioisotopes; Prostatic Neoplasms | 1980 |
Impotence therapy and cancer of the prostate.
Topics: Adenocarcinoma; Aged; Diethylstilbestrol; Drug Administration Schedule; Erectile Dysfunction; Fluoxymesterone; Humans; Male; Middle Aged; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms | 1976 |
Hemostatic effects of hormonal stimulation in patients with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Androgens; Antineoplastic Agents; Disseminated Intravascular Coagulation; Fluoxymesterone; Hemostasis; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Stimulation, Chemical; Testosterone; Thrombosis | 1988 |
Estramustine phosphate (estracyt) following androgens in men with refractory stage D2 prostate cancer.
Topics: Aged; Drug Interactions; Estramustine; Fluoxymesterone; Humans; Male; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Orchiectomy; Prostatic Neoplasms | 1988 |
Cytotoxic chemotherapy and androgen priming in patients with advanced carcinoma of the prostate. A phase II trial of the Piedmont Oncology Association.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Drug Evaluation; Fluoxymesterone; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Vincristine | 1985 |
Feedback regulation of gonadotropin secretion in men.
Topics: Adult; Aged; Atrophy; Castration; Ethinyl Estradiol; Feedback; Fluoxymesterone; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Radioimmunoassay; Spermatogenesis; Testis; Testosterone | 1973 |
Fluoride therapy for pain in malignant bone disease.
Topics: Adult; Aged; Analgesia; Bone Neoplasms; Breast Neoplasms; Estrogens; Fluorides; Fluoxymesterone; Humans; Male; Methotrexate; Middle Aged; Multiple Myeloma; Neoplasm Metastasis; Paraganglia, Nonchromaffin; Prednisone; Prostatic Neoplasms; Thiotepa | 1968 |